Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

QCT of the proximal femur—which parameters should be measured to discriminate hip fracture?

(2015) O. Museyko et al.   OSTEOPOROSIS INTERNATIONAL

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

(2014) Michael R. McClung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody

(2013) Michael S Ominsky et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study

(2013) Desmond Padhi et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Advanced CT based In Vivo Methods for the Assessment of Bone Density, Structure, and Strength

(2013) K. Engelke et al.   Current Osteoporosis Reports

Proximal femoral density distribution and structure in relation to age and hip fracture risk in women

(2012) Julio Carballido-Gamio et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis

(2011) R. Rizzoli et al.   OSTEOPOROSIS INTERNATIONAL

Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis

(2010) Klaus Engelke et al.   BONE

A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

(2010) Andrew J Burghardt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

(2010) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

(2010) Desmond Padhi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

(2010) Michael S Ominsky et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Differences in femoral neck geometry associated with age and ethnicity

(2010) K. M. Kim et al.   OSTEOPOROSIS INTERNATIONAL

Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

(2010) H. M. Macdonald et al.   OSTEOPOROSIS INTERNATIONAL

Microarchitecture, the key to bone quality

(2009) M. L. Brandi   RHEUMATOLOGY

Reanalysis precision of 3D quantitative computed tomography (QCT) of the spine

(2008) Klaus Engelke et al.   BONE

Severity of Vertebral Fractures Is Associated With Alterations of Cortical Architecture in Postmenopausal Women

(2008) Elisabeth Sornay-Rendu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Clinical Use of Quantitative Computed Tomography and Peripheral Quantitative Computed Tomography in the Management of Osteoporosis in Adults: The 2007 ISCD Official Positions

(2008) Klaus Engelke et al.   JOURNAL OF CLINICAL DENSITOMETRY